Pam Holland, Ph.D.

Senior Vice President, Biology at InduPro

Speaker

Pam Holland joined InduPro in May of 2023 as InduPro’s Senior Vice President of Biology to oversee pipeline development and contribute to the execution of InduPro’s strategic objectives.

Prior to joining InduPro, Pam was Sr. Vice President of Research at Alpine Immune Sciences, where she was responsible for overseeing the development and advancement of internal research programs and managing external pre-clinical collaborations. These included protein-based candidate therapeutics derived from an internal directed-evolution platform utilizing novel protein engineering strategies, aimed at both oncology and autoimmune/inflammation therapeutic areas.

Prior to joining Alpine, Pam served as Vice President, Cancer Biology at Surface Oncology in Cambridge MA, overseeing biology and immunology research. During her tenure she played key roles in developing the Surface pipeline, driving multiple pre-clinical programs into Phase 1, as well as the establishment of an early strategic partnership with Novartis and later with GSK. Prior to joining Surface, Pam held roles of increasing responsibility in oncology research at Amgen, working extensively on TNF-receptor superfamily members including death-receptor agonists. Members of her team were instrumental in the development of multiple discovery programs for cancer immunotherapy.

Pam received her bachelor’s degree from the University of California, San Diego and her PhD from the University of Washington/Fred Hutchinson Cancer Research Center in the lab of Dr. Jonathan Cooper. She also held a post-doctoral position at Immunex prior to the Amgen acquisition. Before graduate school, Pam worked at Cetus Corporation in Emeryville, CA where she was a key contributor to the development of TaqMan™. She is a co-inventor on all TaqMan patents and was the lead author on the first publication describing TaqMan in 1991.